stella
beta
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial — Stella
Home
/
ICAD - Intracranial Atherosclerotic Disease
/
View on ClinicalTrials.gov
Recruiting
Back to ICAD - Intracranial Atherosclerotic Disease trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(18 sites)
China
Beijing Tiantan Hospital, Beijing, Beijing Municipality
Beijing Daxing District People's Hospital, Beijing, Beijing Municipality
Hejian People's Hospital, Cangzhou, Hebei
North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei
Xingtai City Third Hospital, Xingtai, Hebei
General Hospital of The Yangtze River Shipping, Wuhan, Hubei
Baotou Central Hospital, Baotou, Inner Mongolia
Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia
Tongliao City Hospital, Tongliao, Inner Mongolia
Wuhai People's Hospital, Wuhai, Inner Mongolia
The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu
The Second Norman Bethune Hospital of JilinUniversity,, Changchun, Jilin
General Hospital of Benxi Iron and Steel Co, Benxi, Liaoning
Shanxi Cardiovascular Hospital, Taiyuan, Shanxi
Shanxi Provincial People's Hospital, Taiyuan, Shanxi
The First Affiliated Hospital of College of Medicine, Hangzhou, Zhejiang
Lishui People's Hospital, Lishui, Zhejiang
Beilun People's Hospital of Ningbo City, Ningbo, Zhejiang